129 related articles for article (PubMed ID: 9074390)
1. Ocular myasthenia gravis.
McQuillen MP
Arch Neurol; 1997 Mar; 54(3):229. PubMed ID: 9074390
[No Abstract] [Full Text] [Related]
2. Correlation of the clinical response to ACTH treatment with the endocrine status in myasthenia gravis.
Cape CA; Arbona NJ
South Med J; 1973 Sep; 66(9):1011-3. PubMed ID: 4354772
[No Abstract] [Full Text] [Related]
3. Corticotropin therapy in myasthenia gravis: indications and limitations.
Namba T; Shapiro MS; Brunner NG; Grob D
Neurology; 1970 Apr; 20(4):385. PubMed ID: 4327339
[No Abstract] [Full Text] [Related]
4. Maintenance adrenocorticotropic hormone (ACTH) treatment in myasthenia gravis.
Cape CA; Utterback RA
Neurology; 1972 Nov; 22(11):1160-4. PubMed ID: 4343649
[No Abstract] [Full Text] [Related]
5. Corticotropin therapy in myasthenia gravis: effects, indications, and limitations.
Namba T; Brunner NG; Shapiro MS; Grob D
Neurology; 1971 Oct; 21(10):1008-18. PubMed ID: 4329627
[No Abstract] [Full Text] [Related]
6. Ocular response to corticotropin in myasthenia gravis.
Cape CA
Arch Ophthalmol; 1973 Oct; 90(4):292-3. PubMed ID: 4355713
[No Abstract] [Full Text] [Related]
7. Medical and surgical treatment for ocular myasthenia.
Benatar M; Kaminski H
Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623
[TBL] [Abstract][Full Text] [Related]
8. Results with ACTH and spironolactone in severe cases of myasthenia gravis.
von Reis G; Liljestrand A; Matell G
Acta Neurol Scand Suppl; 1965; 13 Pt 2():463-71. PubMed ID: 4284453
[No Abstract] [Full Text] [Related]
9. Controlled clinical trials of anything in myasthenia gravis.
Pascuzzi RM
Arch Neurol; 1997 Nov; 54(11):1323. PubMed ID: 9362974
[No Abstract] [Full Text] [Related]
10. Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.
Grob D; Namba T
JAMA; 1966 Nov; 198(7):703-7. PubMed ID: 4288482
[No Abstract] [Full Text] [Related]
11. [Diagnosis and treatment of ocular myasthenia (author's transl)].
Huber A
Klin Monbl Augenheilkd; 1977 Dec; 171(6):889-95. PubMed ID: 203742
[TBL] [Abstract][Full Text] [Related]
12. Benefit from adrenocorticotrophin in myasthenia gravis.
Liversedge LA; Yuill GM; Wilkinson IM; Hughes JA
J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):412-5. PubMed ID: 4365243
[TBL] [Abstract][Full Text] [Related]
13. The use of ACTH and corticosteroids in myasthenia gravis.
Genkins G; Kornfeld P; Osserman KE; Namba T; Grob D; Brunner NG
Ann N Y Acad Sci; 1971 Sep; 183():369-74. PubMed ID: 4330763
[No Abstract] [Full Text] [Related]
14. Myasthenia gravis: generalized vs ocular, and children vs adults.
Wang HS
Arch Neurol; 2003 Oct; 60(10):1491; author reply 1492. PubMed ID: 14568824
[No Abstract] [Full Text] [Related]
15. Myasthenia gravis treated with ACTH.
Day J
Nurs Times; 1967 Dec; 63(50):1695-6. PubMed ID: 4294739
[No Abstract] [Full Text] [Related]
16. [Treatment of myasthenia with corticotropic hormones].
Goulon M; Barois A; Gajdos P; Grosbuis S; Joron MH; Bennaiche M
Sem Hop; 1972 Dec; 48(51):3371-5. PubMed ID: 4347494
[No Abstract] [Full Text] [Related]
17. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
Brunner NG; Berger CL; Namba T; Grob D
Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
[TBL] [Abstract][Full Text] [Related]
18. Oral corticosteroids in the treatment of ocular myasthenia gravis.
Fischer KC; Schwartzman RJ
Ann N Y Acad Sci; 1976; 274():652-8. PubMed ID: 1067001
[No Abstract] [Full Text] [Related]
19. [On the therapy of myasthenia gravis. (Presentation of a case)].
Henriquet F; Balestra L
Minerva Anestesiol; 1970 Apr; 36(4):277-81. PubMed ID: 4320560
[No Abstract] [Full Text] [Related]
20. Severe occult juvenile myasthenia gravis responsive to long-term corticosteroid therapy.
Griggs RC; McFarlin DE; Engel WK
Trans Am Neurol Assoc; 1968; 93():216-8. PubMed ID: 4304254
[No Abstract] [Full Text] [Related]
[Next] [New Search]
